PK
Pradeep Kumar Muraleedharannair
About Pradeep Kumar Muraleedharannair
Data last updated:
Pradeep Kumar Muraleedharannair is a Director at Citwal Pharmaceuticals Private Limited (since 2018). The company operates in Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Citwal Pharmaceuticals Private Limited U74999KL2018PTC052557 | Director | 21 Mar 2018 | 2018 | Active |
Board colleagues of Pradeep Kumar Muraleedharannair
| Name | DIN | Company | Designation |
|---|---|---|---|
| Navas Abdul Rehuman | 08091742 | Citwal Pharmaceuticals Private Limited | Director |
| Vasumathi Nadarajan Rijees | 07480073 | Citwal Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Kumar Muraleedharannair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Kumar Muraleedharannair
Pradeep Kumar Muraleedharannair currently holds 1 directorship: Citwal Pharmaceuticals Private Limited (Director, since 21 Mar 2018).
Pradeep Kumar Muraleedharannair was first appointed on 21 Mar 2018 as Director at Citwal Pharmaceuticals Private Limited.
The current boards of Pradeep Kumar Muraleedharannair's companies include Navas Abdul Rehuman (Citwal Pharmaceuticals Private Limited), Vasumathi Nadarajan Rijees (Citwal Pharmaceuticals Private Limited).